514 related articles for article (PubMed ID: 26924526)
1. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
[TBL] [Abstract][Full Text] [Related]
2. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
3. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
[TBL] [Abstract][Full Text] [Related]
4. The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.
Mintz MA; Felce JH; Chou MY; Mayya V; Xu Y; Shui JW; An J; Li Z; Marson A; Okada T; Ware CF; Kronenberg M; Dustin ML; Cyster JG
Immunity; 2019 Aug; 51(2):310-323.e7. PubMed ID: 31204070
[TBL] [Abstract][Full Text] [Related]
5. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
[TBL] [Abstract][Full Text] [Related]
6. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
[TBL] [Abstract][Full Text] [Related]
7. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.
Zhang M; Howard K; Winters A; Steavenson S; Anderson S; Smelt S; Doellgast G; Sheelo C; Stevens J; Kim H; Hamburger A; Sein A; Caughey DJ; Lee F; Hsu H; Siu G; Byrne FR
Clin Exp Immunol; 2011 Jan; 163(1):77-87. PubMed ID: 21078085
[TBL] [Abstract][Full Text] [Related]
9. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.
del Rio ML; Jones ND; Buhler L; Norris P; Shintani Y; Ware CF; Rodriguez-Barbosa JI
J Immunol; 2012 May; 188(10):4885-96. PubMed ID: 22490863
[TBL] [Abstract][Full Text] [Related]
11. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.
Flynn R; Du J; Veenstra RG; Reichenbach DK; Panoskaltsis-Mortari A; Taylor PA; Freeman GJ; Serody JS; Murphy WJ; Munn DH; Sarantopoulos S; Luznik L; Maillard I; Koreth J; Cutler C; Soiffer RJ; Antin JH; Ritz J; Dubovsky JA; Byrd JC; MacDonald KP; Hill GR; Blazar BR
Blood; 2014 Jun; 123(25):3988-98. PubMed ID: 24820310
[TBL] [Abstract][Full Text] [Related]
12. IL-21 Receptor Blockade Shifts the Follicular T Cell Balance and Reduces
Nian Y; Xiong Z; Zhan P; Wang Z; Xu Y; Wei J; Zhao J; Fu Y
Front Immunol; 2021; 12():661580. PubMed ID: 33897706
[TBL] [Abstract][Full Text] [Related]
13. Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.
Sakoda Y; Park JJ; Zhao Y; Kuramasu A; Geng D; Liu Y; Davila E; Tamada K
Blood; 2011 Feb; 117(8):2506-14. PubMed ID: 21220749
[TBL] [Abstract][Full Text] [Related]
14. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
Cheung TC
Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
[TBL] [Abstract][Full Text] [Related]
15. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
Tao R; Wang L; Han R; Wang T; Ye Q; Honjo T; Murphy TL; Murphy KM; Hancock WW
J Immunol; 2005 Nov; 175(9):5774-82. PubMed ID: 16237069
[TBL] [Abstract][Full Text] [Related]
17. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
18. B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses.
Kashiwakuma D; Suto A; Hiramatsu Y; Ikeda K; Takatori H; Suzuki K; Kagami S; Hirose K; Watanabe N; Iwamoto I; Nakajima H
J Immunol; 2010 Sep; 185(5):2730-6. PubMed ID: 20660710
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier.
Del Rio ML; Bravo Moral AM; Fernandez-Renedo C; Buhler L; Perez-Simon JA; Chaloin O; Alvarez Nogal R; Fernandez-Caso M; Rodriguez-Barbosa JI
Transl Res; 2017 Mar; 181():83-95.e3. PubMed ID: 27702550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]